Who owns the CRISPR-X trademark?

The CRISPR-X trademark is owned by CRISPR Therapeutics AG.

What class is the CRISPR-X trademark registered in?

The CRISPR-X trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for CRISPR-X?

The USPTO serial number for CRISPR-X is 99555280.

What is the registration number for CRISPR-X?

CRISPR-X is registered under USPTO registration number 0.

Sealvo

Home Search: CRISPR-XCRISPR-X #99555280

Back

Updated Oct 27, 2026·35 searches this week

View on USPTO TSDR Find similar marks

CRI

USPTO Trademark Record

PENDING

CRISPR-X

SN 99555280·Reg 0·Filed Dec 18, 2025

Owner CRISPR Therapeutics AG

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CRISPR-X (Serial No. 99555280), Registration No. 0, is a pending US trademark filed on Dec 18, 2025 by CRISPR Therapeutics AG. This trademark covers Class 042 (Scientific, technology & SaaS services).

Statement of Use due: February 18, 2027114 days remaining

Mark Intelligence

CRISPR-X (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 18, 2025

SERIAL

99555280

REG#

Filing Information

StatusPENDING

Filing DateDec 18, 2025

Serial Number99555280

Registration No.0

Status DateAug 18, 2026

Published for OppositionJun 23, 2026

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

19 events

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 18, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 23, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 23, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 17, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

May 22, 2026

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 22, 2026

EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 22, 2026

EXAMINER'S AMENDMENT ENTERED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 22, 2026

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 22, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 18, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 18, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 18, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Apr 28, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 28, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 28, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 21, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 09, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 18, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Dec 18, 2025

APPLICATION FILING RECEIPT MAILED

Other Marks by CRISPR Therapeutics AG

Additional USPTO filings from the same owner.

CRI

CRISPR-X

98247548

CRISPR Therapeutics AG

REGISTERED

CRI

CRISPR THERAPEUTICS

87872234

CRISPR Therapeutics AG

REGISTERED

CRI

CRISPR THERAPEUTICS

87980024

CRISPR Therapeutics AG

REGISTERED

CRI

CRISPR THERAPEUTICS

87980023

CRISPR Therapeutics AG

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

CRI

CRISPR-X

98247548

CRISPR Therapeutics AG

REGISTERED

STA

STAR-CRISPR

79426106

Celyntra Therapeutics SA

REGISTERED

CRI

CRISPR THERAPEUTICS

87980024

CRISPR Therapeutics AG

REGISTERED

CRI

CRISPR THERAPEUTICS

87980023

CRISPR Therapeutics AG

REGISTERED

Other Marks by Tiffany D. Gehrke

Additional USPTO filings handled by the same attorney of record.

ELG

EL GRITO CHICAGO

99066675

REGISTERED

CRI

CRISPR-X

98247548

REGISTERED

HAM

HAMACHI

99975887

REGISTERED

MEG

MEGA SPORTS CAMP

78947239

REGISTERED

CRISPR-X

Run a conflict check

Other Marks by CRISPR Therapeutics AG

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Tiffany D. Gehrke

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company